Oppenheimer Asset Management’s Sage Therapeutics SAGE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-1,568
| Closed | -$113K | – | 1617 |
|
|
2019
Q4 | $113K | Sell |
1,568
-2,929
| -65% | -$211K | ﹤0.01% | 1170 |
|
|
2019
Q3 | $631K | Sell |
4,497
-225
| -5% | -$31.6K | 0.01% | 746 |
|
|
2019
Q2 | $865K | Sell |
4,722
-143
| -3% | -$26.2K | 0.02% | 662 |
|
|
2019
Q1 | $774K | Buy |
4,865
+874
| +22% | +$139K | 0.02% | 678 |
|
|
2018
Q4 | $382K | Sell |
3,991
-328
| -8% | -$31.4K | 0.01% | 837 |
|
|
2018
Q3 | $610K | Buy |
4,319
+377
| +10% | +$53.2K | 0.01% | 756 |
|
|
2018
Q2 | $617K | Buy |
3,942
+1,860
| +89% | +$291K | 0.02% | 733 |
|
|
2018
Q1 | $335K | Buy |
+2,082
| New | +$335K | 0.01% | 902 |
|
|
2017
Q4 | – | Sell |
-1,944
| Closed | -$122K | – | 1407 |
|
|
2017
Q3 | $122K | Buy |
1,944
+1,565
| +413% | +$98.2K | ﹤0.01% | 1151 |
|
|
2017
Q2 | $30K | Sell |
379
-4
| -1% | -$317 | ﹤0.01% | 1442 |
|
|
2017
Q1 | $27K | Buy |
+383
| New | +$27K | ﹤0.01% | 1441 |
|